Navigation Links
ViewPoint CK System (Conductive Keratoplasty)

ProductsViewPoint CK System (Conductive Keratoplasty)
Company Refractec, Inc.
Item ViewPoint CK System (Conductive Keratoplasty)
Features Presbyopic Indications
Approval of the premarket approval application supplement for the Refractec ViewPoint CK System is for the temporary induction of myopia (-1.00 D to -2.00 D) to improve near vision in the non-dominant eye of presbyopic hyperopes or presbyopic emmetropes, via spherical hyperopic treatment of 1.00 D to 2.25 D, in patients 40 years of age or greater with a documented stability of refraction for the prior 12 months, as demonstrated by a change of < 0.50 D in spherical and cylindrical components of the manifest refraction, and with = 0.75 D of cycloplegic refractive cylinder and with a successful preoperative trial of monovision or history of monovision wear (i.e., dominant eye corrected for distance vision and non-dominant eye corrected for near vision).

Hyperopic Indications
The Refractec ViewPoint CK System is for the temporary reduction of spherical hyperopia in patients who have 0.75 D to 3.25 D of cycloplegic spherical hyperopia, less than or equal to 0.75 D of refractive astigmatism (minus cylinder format), and a cycloplegic spherical equivalent of +0.75 D to +3.00 D. Patients must be 40 years of age or greater with a documented stability of refraction for the prior 12 months, as demonstrated by a change of less than 0.50 D in spherical and cylindrical components of manifest refraction. The magnitude of correction with this treatment diminishes over time, with some patients retaining some or all of their intended refractive correction.

Description NearVision™ CK is the only procedure designed for patients with a spherical hyperopia between +0.75 D and +3.00 D or presbyopic patients who would benefit from a spherical treatment of between 1.00 D and 2.25 D to achieve a myopic endpoint of between -1.00 D and -2.00 D in their non-dominant eye to temporarily improve near vision. CK is unique in that it uses radiofrequency (RF) instead of a laser. It takes as little as three minutes and can be conveniently performed in-office using the ViewPoint CK System.

NearVision CK builds upon the principles of thermokeratoplasty, using radiofrequency (RF) energy to temporarily reshape the cornea and therefore adjust its refractive characteristics.

RF energy and its application
To perform the procedure, a handpiece with a Keratoplast™ Tip delivers controlled RF energy directly to the internal corneal tissue in a ring pattern. The tip serves as an RF antenna while the speculum holding the eye open serves as the return path. By applying RF energy to the tissue, Ohm's law (V = I R) defines a consistent relationship that determines the heat generated. The voltage (V) determines the electrical field strength within the tissue while the current (I) is defined by the treatment parameters. Impedance is a characteristic of tissue.

The characteristics of the energy (i.e., current, waveform, frequency, rep rate and crest factor) and the tissue's consistent conductive properties make it possible for CK to achieve a reproducible, optimal tissue temperature for the critical time necessary to bring about the localized shrinkage of the collagen fibers.

Depth of procedure and effects
CK creates a purse-string effect that steepens the central cornea through a ring of application spots around the periphery of the cornea. Several studies have concluded that the depth of shrinkage determines the degree of corneal correction permanency. Because of the intrastromal delivery of RF energy, CK produces collagen shrinkage that encompasses 80% of the corneal thickness.

Info Refractec, Inc.
Customer Service: (800) 752-9544
Web site: http://www.refractec.com

Related medicine products :

1. Silicone Oil Cannula System - 20 Gauge
2. Silicone Oil Cannula System - 19 Gauge
3. SuperVu Galilean System
4. KOWA nonmyd 7 / VK-2 Digital Imaging System
5. KOWA nonmyd a-D / VK-2 Digital Imaging System
6. Refraction System RT-2100
7. Odyssey Phacoemulsification System
8. SIStem Phacoemulsification System
9. Precisionist Phacoemulsification System
10. Photon Laser Phacoemulsification System
11. Phaco-Emulsification System
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
... Ophthalmics offers the most comprehensive family ... Instruments for Cataract incision, Glaucoma filtration, ... coagulation is achieved with minimal tissue ... Straight eraser styles are available in ...
... Medtronic Ophthalmics offers the most comprehensive ... Eraser Instruments for Cataract incision, Glaucoma ... discrete coagulation is achieved with minimal ... necrosis. Straight eraser styles are available ...
... Medtronic Ophthalmics offers the most comprehensive ... Eraser Instruments for Cataract incision, Glaucoma ... discrete coagulation is achieved with minimal ... necrosis. Straight eraser styles are available ...
Medicine Products:
(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 clinicians ... Clinicians who participate in APMs are paid for the quality of care they give ... build a system that delivers better care and one in which clinicians work together ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network announced the ... 503A compounding pharmacy located in Ocala, Florida. , Meeting the Needs of ... the United States for high-quality human anti-aging and wellness compounded medications, ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots , ... from around the world, announces the launch of its newly redesigned website. The ... to research breakthroughs and trending news, vital information on upcoming virtual events and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... certified dermatologist by the American Board of Dermatology and fellowship trained Mohs and ... the National Institutes of Health, Dr. Li completed his internship in internal medicine ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... 19, 2017 The global  pacemaker market  is expected to ... View Research, Inc. The heightening prevalence of cardiac conditions coupled with the availability ... globally. In addition, technological enhancements in these devices are supporting the expansion of ... ... Grand View Research Logo ...
(Date:1/19/2017)... Md. , Jan. 18, 2017   ... late-stage clinical company developing therapeutics designed to preserve ... of patients, today confirmed plans to initiate a ... Company,s modified-release reformulation of lovastatin lactone designed to ... smithii) in the gut to treat the ...
Breaking Medicine Technology: